Hanjo Hennemann at Nexigen to Speak at 5th Assay Conference Sept 20-21 San Diego
Hanjo Hennemann, CEO/CSO at Nexigen GmbH, to speak at GTCbio’s 5th Assay and Drug Discovery Technologies on Sept. 20-21, 2010 in San Diego, CA.
Genentech to Speak at 5th Assay Conference Sept 20-21, 2010 San Diego, CA
Laura DeForge, Senior Scientist at Genentech, Inc, will give a presentation on “Real-time Impedance-based Bioassays Using the xCELLigence™ Technology.” at 5th Assay and Drug Discovery Technologies Conference to be held this year in San Diego, CA Sept. 20-21, 2010 by GTCbio. xCELLigence is a cell-based assay platform that allows for real-time, label-free monitoring of cellular responses by measuring electrical impedance. Benefits of xCELLigence include: Real-time data collection over the course of the experiment yields more information than endpoint assays, the readout is label free and does not interfere with cell growth or response, and assay development is rapid, with minimal hands-on time with simple operation
Robert Bostwick, Director, CNS and Pain HTS Center AstraZeneca Pharmaceuticals, to Give Presentation at 5th Assay and Drug Discovery Technologies (San Diego, CA Sept. 20-21, 2010)
Robert Bostwick, Director, CNS and Pain HTS Center AstraZeneca Pharmaceuticals, to speak at GTCbio’s 5th Assay and Drug Discovery Technologies on Sept. 20-21, 2010 in San Diego, CA.
Ruchira Das Gupta, Associate Director at Adnexus, a Bristol-Myers Squibb R&D company, to Give Presentation at 5th Assay and Drug Discovery Technologies (San Diego, CA Sept. 20-21, 2010)
Laura Ruchira Das Gupta, Associate Director at Adnexus, a Bristol-Myers Squibb R&D company, to speak at GTCbio’s 5th Assay and Drug Discovery Technologies on Sept. 20-21, 2010 in San Diego, CA.
Katy Spink of Geron to give Featured Presentation at Annual Stem Cell Conference
Katy Spink, Vice President of Operations for Geron, will give the Featured presentation at GTCbio’s 6th Stem Cell Research & Therapeutics Conference, May 27-28, 2010 in Boston, MA.
Barbara Wirostko, Pfizer – to Present at the 2nd Annual Ocular Disease Conference
Barbara Wirostko, Senior Medical Director, Team Lead Ophthalmology, Pfizer will give a presentation at GTCbio’s 2nd Annual Ocular Disease Drug & Discovery Conference, May 27 – 28, 2010 in Boston, MA.
Vaccines: All Things Considered Conference to Be Held by GTCbio on November 9-10, 2009 in Washington, DC
GTCbio is proud to present its 7th Annual Vaccines: “All Things Considered” conference to be held this year in Washington, D.C. on Nov 9-10, 2009. This conference promises to be the one-stop destination to gain updates and exposure on all aspects of vaccine research, development, regulations, and policy.
A. Roses Director Dean Institute, Keynote at Drug Discovery & Development Summit
Allen Rose, Director of The Deane Drug Discovery Institute – Duke University, is to give a keynote presentation at GTCbio’s 5th Modern Drug Discovery & Development Summit, on October 14th-16th, 2009, in San Diego, CA.
Amy M. Scott-Billman, Vice President of Global Regulatory Strategy for Immunotherapeutics at GlaxoSmithKline Biologicals, to Give Keynote Presentation at GTCbio’s 5th Modern Drug Discovery & Development Summit on October 14-16, 2009 in San Diego, CA
Amy Scott-Billman, Vice President of Global Regulatory Strategy for Immunotherapeutics at GlaxoSmithKline Biologicals, is to give a keynote presentation concerning regulatory considerations & challenges for immunotherapeutic/diagnostic co-development at GTCbio’s 5th Modern Drug Discovery & Development Summit, on October 14th-16th, 2009, in San Diego, CA.